Nicholas James Campion
Overview
Explore the profile of Nicholas James Campion including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gangl K, Liu D, Bartosik T, Campion N, Vyskocil E, Mueller C, et al.
J Pers Med
. 2024 Apr;
14(4).
PMID: 38672965
(1) Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) has a high rate of recurrence in patients, despite therapy with local corticosteroids and functional endoscopic sinus surgery. Dupilumab, a recombinant monoclonal...
2.
Brkic F, Liu D, Rucklinger I, Campion N, Bartosik T, Vyskocil E, et al.
J Otolaryngol Head Neck Surg
. 2023 Nov;
52(1):75.
PMID: 38007429
Background: Dupilumab is a monoclonal antibody against interleukin 4 receptor alpha and has proven to be clinically effective in treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). However, a...
3.
Campion N, Doralt A, Lupinek C, Berger M, Poglitsch K, Brugger J, et al.
Allergy
. 2023 Jan;
78(6):1687-1691.
PMID: 36691369
No abstract available.
4.
Rocha-Hasler M, Muller L, Wagner A, Tu A, Stanek V, Campion N, et al.
Front Immunol
. 2022 Dec;
13:1004583.
PMID: 36578479
Mass cytometry (MC) is a powerful method for mapping complex cellular systems at single-cell levels, based on the detection of cellular proteins. Numerous studies have been performed using human blood,...
5.
Schneider S, Poglitsch K, Morgenstern C, Quint T, Gangl K, Sinz C, et al.
Eur Respir J
. 2022 Dec;
61(3).
PMID: 36549708
Background: Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) comprises the triad of chronic rhinosinusitis with nasal polyps, asthma and intolerance to NSAIDs. Dupilumab treatment, targeting the interleukin-4 (IL-4) receptor α,...
6.
Bangert C, Villazala-Merino S, Fahrenberger M, Krausgruber T, Bauer W, Stanek V, et al.
Front Immunol
. 2022 Apr;
13:850494.
PMID: 35418991
Chronic rhinosinusitis with nasal polyps is affecting up to 3% of Western populations. About 10% of patients with nasal polyps also suffer from asthma and intolerance to aspirin, a syndrome...
7.
Campion N, Kohler R, Ristl R, Villazala-Merino S, Eckl-Dorna J, Niederberger-Leppin V
J Allergy Clin Immunol Pract
. 2021 Jul;
9(11):4117-4129.e2.
PMID: 34265447
Background: Although chronic rhinosinusitis with nasal polyps is a common inflammatory condition with significant morbidity and financial cost, information regarding prevalence and disease burden of this condition is scarce. Objective:...
8.
Brkic F, Liu D, Campion N, Leonhard M, Altumbabic S, Korlatovic M, et al.
J Voice
. 2020 Jul;
36(3):438.e19-438.e24.
PMID: 32703724
Background: Adenotonsillectomy is one of the most common pediatric surgical procedures. Postoperative voice changes are a very common concern among patient's parents. Therefore, the aim of this study is to...
9.
Eckl-Dorna J, Villazala-Merino S, Campion N, Byazrova M, Filatov A, Kudlay D, et al.
Cells
. 2019 Aug;
8(9).
PMID: 31466324
Immunoglobulin E (IgE) is the key immunoglobulin in the pathogenesis of IgE associated allergic diseases affecting 30% of the world population. Recent data suggest that allergen-specific IgE levels in serum...